Lodo Therapeutics Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
30
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$25.4M
Lodo Therapeutics General Information
Description
Developer of novel cancer and anti-infective therapeutics created to address undruggable targets with high unmet need. The company applies advanced technologies to tap the vast collections of undiscovered molecules encoded in microbial DNA that is extracted from the environment, enabling healthcare providers to treat drug-resistant microbial infections and cancers.
Contact Information
Website
www.lodotherapeutics.comCorporate Office
- 430 East 29th Street
- Suite 625
- New York, NY 10016
- United States
Corporate Office
- 430 East 29th Street
- Suite 625
- New York, NY 10016
- United States
Lodo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 16-May-2021 | $25.4M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 18-Jan-2016 | Completed | Generating Revenue |
Lodo Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Lodo Therapeutics Comparisons
Industry
Financing
Details
Lodo Therapeutics Competitors (26)
One of Lodo Therapeutics’s 26 competitors is Visterra, a Formerly VC-backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Visterra | Formerly VC-backed | Waltham, MA | ||||
| CalciMedica | Formerly VC-backed | San Diego, CA | ||||
| Cullgen | Pending Transaction (M&A) | San Diego, CA | ||||
| Flare Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| Exo Therapeutics | Venture Capital-Backed | Cambridge, MA |
Lodo Therapeutics Patents
Lodo Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240140992-A1 | Hexadepsipeptide compounds and methods of using the same | Pending | 22-Feb-2021 | ||
| US-20230049048-A1 | Methods and apparatus for efficient and accurate assembly of long-read genomic sequences | Pending | 07-Feb-2020 |
Lodo Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lodo Therapeutics Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 180 Degree Capital | Hedge Fund | Minority | ||
| ARCH Venture Partners | Venture Capital | Minority | ||
| AbbVie Ventures | Corporate Venture Capital | Minority | ||
| Accelerator Life Science Partners | Venture Capital | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority |
Lodo Therapeutics Acquisitions (2)
Lodo Therapeutics’s most recent deal was a Merger/Acquisition with Hibiskus BioPharma. The deal was made on 03-Sep-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hibiskus BioPharma | 03-Sep-2020 | Merger/Acquisition | Biotechnology | ||
| Conifer Point Pharmaceuticals | 06-Aug-2020 | Merger/Acquisition | Discovery Tools (Healthcare) |
Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Conifer Point Pharmaceuticals | Doylestown, PA | 2014 |
Lodo Therapeutics FAQs
-
When was Lodo Therapeutics founded?
Lodo Therapeutics was founded in 2015.
-
Where is Lodo Therapeutics headquartered?
Lodo Therapeutics is headquartered in New York, NY.
-
What is the size of Lodo Therapeutics?
Lodo Therapeutics has 30 total employees.
-
What industry is Lodo Therapeutics in?
Lodo Therapeutics’s primary industry is Drug Discovery.
-
Is Lodo Therapeutics a private or public company?
Lodo Therapeutics is a Private company.
-
What is the current valuation of Lodo Therapeutics?
The current valuation of Lodo Therapeutics is .
-
What is Lodo Therapeutics’s current revenue?
The current revenue for Lodo Therapeutics is .
-
How much funding has Lodo Therapeutics raised over time?
Lodo Therapeutics has raised $19.9M.
-
Who are Lodo Therapeutics’s investors?
180 Degree Capital, ARCH Venture Partners, AbbVie Ventures, Accelerator Life Science Partners, and Alexandria Venture Investments are 5 of 13 investors who have invested in Lodo Therapeutics.
-
Who are Lodo Therapeutics’s competitors?
Visterra, CalciMedica, Cullgen, Flare Therapeutics, and Exo Therapeutics are some of the 26 competitors of Lodo Therapeutics.
-
When was Lodo Therapeutics acquired?
Lodo Therapeutics was acquired on 16-May-2021.
-
Who acquired Lodo Therapeutics?
Lodo Therapeutics was acquired by Zymergen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
